AZNASTRAZENECA PLC

Nasdaq astrazeneca.com


$ 80.53 $ -0.63 (-0.78 %)    

Wednesday, 11-Sep-2024 15:59:59 EDT
QQQ $ 468.28 $ 12.08 (2.65 %)
DIA $ 409.73 $ 1.01 (0.25 %)
SPY $ 554.79 $ 6.00 (1.09 %)
TLT $ 100.61 $ -0.08 (-0.08 %)
GLD $ 232.25 $ -0.37 (-0.16 %)
$ 80.53
$ 80.46
$ 80.52 x 116
$ 80.54 x 200
$ 79.75 - $ 80.66
$ 58.30 - $ 87.68
4,097,244
na
124.84B
$ 0.56
$ 7.30
TBD
na
na ($ 0.03)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
No Data found
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 erste-group-upgrades-astrazeneca-to-buy

Erste Group analyst Hans Engel upgrades AstraZeneca (NASDAQ:AZN) from Hold to Buy.

Core News & Articles

The companies commit to bring cutting-edge liquid biopsy testing to 20 institutions globally over the next 12 monthsBOSTON and ...

 pillar-biosciences-partners-with-astrazeneca-to-help-accelerate-access-to-liquid-biopsy-testing

- Reuters

 astrazeneca-ceo-pascal-soriot-updates-on-chinese-compliance-probe-and-lung-cancer-drug-trial-results

Chinese authorities have detained AstraZeneca employees amid a probe into potential data privacy breaches and unlicensed drug i...

 astrazenecas-investigational-cancer-drug-disappoints-in-late-stage-lung-cancer-trial

AstraZeneca shared detailed results from the TROPION-Lung01 Phase 3 trial of datopotamab deruxtecan for non-small cell lung can...

 enliven-therapeutics-leukemia-candidate-could-challenge-pfizer-astrazeneca-in-broader-target-market-analyst

HC Wainwright initiated coverage on Enliven Therapeutics, noting its innovative small molecules for tumor treatments. HC Wainwr...

Core News & Articles

The preliminary data of three arms were presented at WCLC, namely: Arm 1: oleclumab in combination with durvalumab and plati...

 astrazeneca-in-trouble-for-employee-detentions-in-china-over-illegal-activities

Chinese police detain AstraZeneca employees over alleged data privacy breaches and unlicensed drug imports amid an anti-corrupt...

 china-detains-astrazeneca-staff-in-data-drug-import-probes---bloomberg

https://www.bloomberg.com/news/articles/2024-09-05/china-detains-astrazeneca-staff-in-data-drug-import-probes

Core News & Articles

- Reuters 

 despite-medicare-negotiations-americans-may-still-have-to-pay-more-for-prescription-drugs

Despite Medicare's first-ever negotiated drug prices under the Inflation Reduction Act, U.S. costs remain significantly hig...

 astrazeneca-plans-presentations-across-its-portfolio-and-pipeline-at-the-iaslc-2024-world-conference-on-lung-cancer-and-esmo-congress

Across the two meetings, more than 130 abstracts will feature 17 approved and potential new medicines from AstraZeneca includin...

 astrazeneca-threatens-to-move-vaccine-production-amid-reduced-state-support

AstraZeneca may relocate its vaccine manufacturing site from Merseyside to Philadelphia as the UK government considers slashing...

 ozempic-and-wegovy-linked-to-increased-suicidal-thoughts-in-observational-study-but-results-are-contested

A recent study in JAMA Network Open raises concerns about a potential link between GLP-1 drugs Ozempic and Wegovy and an increa...

Core News & Articles

- Reuters 

 johnson--johnson-strikes-17b-deal-to-acquire-heart-tech-innovator-v-wave

Johnson & Johnson to acquire V-Wave for $600 million with potential $1.1 billion in milestone payments. Deal boosts JNJ Med...

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION